1Langley RW,Burch HB.Perioperative management of the thyrotoxic patient[J]. Endocrinol Metab Clin North Am,2003,32(2):519-534.
2Friend DG.Iodide therapy and the importance of quantitating the dose[J].N Engl J Med,1960,263:1358-1360.
3Braga M,Cooper DS.Clinical nreview 129:Oral cholecystographic agents and the thyroid[J].J Clin Endocrinol Metab,2001,86(5):1853-1860.
4Alsanea O,Clark OH.Treatment of Graves' disease:the advantage of surgery[J].Endocrinol Metab Clin North Am,2000,29(2):321-337.
5Muller PE,Bein B,Robens E,et al.Thyroid surgery according to Enderlen-Hotz or Dunhill:a comparison of two surgical methods for the treatment of Graves' disease[J].Int Surg,2001,86(2):112-116.
4Willson RB,Erskine C, Crowe PJ. Hypomagnesemia and hypocalcemia after thyroidectomy: a prospective study [J]. World J Surg, 2000,24 (6) :722 - 6.
5Fewins J, Simpson B, Miller FR. Complications of thyroid and parathyroid surgery [J]. Otolaryngol Clin North Am,2003,36 ( 1 ) : 186 - 9.
6Quirors RM,Prinz RA. Intraoperative parathyroid hormone levels in thyroid surgery are predictive of postoperative hypoparathyroidism and need for vitamin D supplementation [J]. Am J Surg, 2005,189 (1) :306-9.
